Skip to content

This website is intended for UK healthcare professionals only

This is a promotional website developed by AstraZeneca

The prescribing information can be found at the bottom of the page


Tagrisso Case Study: First-Line EGFRm+ NSCLC – 45M

Dr Shobhit Baijal, Consultant Medical Oncologist, University Hospitals Birmingham